home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Apyx Medical Corporation - Common Stock (NQ:APYX)

4.030 +0.140 (+3.60%)

Streaming Delayed Price Updated: 1:58 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

June 09, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Apyx Medical Corporation (APYX)

June 08, 2022

From Robbins LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – APYX

June 08, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Why Are Apyx Medical Shares Trading Higher Today? ↗

May 26, 2022

Via Benzinga

Apyx Medical: Q1 Earnings Insights ↗

May 12, 2022

Apyx Medical (NASDAQ:APYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of APYX Medical Corporation (APYX) Investors

June 08, 2022

From Kirby McInerney LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

June 08, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Apyx Medical Corporation (APYX) Investors of Class Action and Encourages Investors to Contact the Firm

June 08, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

June 08, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

June 07, 2022

From The Schall Law Firm

Via Business Wire

APYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Apyx Medical Corporation

June 07, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm

June 06, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

June 06, 2022

From Law Offices of Howard G. Smith

Via Business Wire

APYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Apyx Medical Corporation

June 06, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher ↗

May 26, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 575 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 26, 2022

Via Benzinga

Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction ↗

May 26, 2022

The U.S. Food and Drug Administration (FDA) announced 510(k) clearance (pre-market notification) of Apyx Medical’s (NASDAQ: APYX) Renuvion Dermal Handpiece for specific dermal resurfacing procedures.

Via Benzinga

Mid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble ↗

May 26, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 1.5% on Thursday.

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.5% In Q1 ↗

May 26, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 200 points on Thursday.

Via Benzinga

61 Stocks Moving In Thursday's Mid-Day Session ↗

May 26, 2022

Via Benzinga

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures

May 26, 2022

From Apyx Medical Corporation

Via Business Wire

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June

May 25, 2022

From Apyx Medical Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022 ↗

May 20, 2022

Upgrades

Via Benzinga

NASDAQ:APYX Investor Notice: Investigation over Possible Securities Laws Violations by Apyx Medical Corporation ↗

May 13, 2022

San Diego, CA -- (SBWIRE) -- 05/13/2022 -- Apyx Medical Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements.

Via SBWire

Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

May 12, 2022

From Apyx Medical Corporation

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 25, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 23, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Apyx Medical Corporation (APYX) on Behalf of Investors

April 22, 2022

From Law Offices of Howard G. Smith

Via Business Wire

APYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corp. on Behalf of Apyx Stockholders and Encourages Investors to Contact the Firm

April 21, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com